• DOI:10.1001/JAMA.286.8.954
Corpus ID: 1117265

Risk of cardiovascular events associated with selective COX-2 inhibitors.

@article{Mukherjee2001RiskOC,
  title={Risk of cardiovascular events associated with selective COX-2 inhibitors.},
  author={D. Mukherjee and S. Nissen and E. Topol},
  journal={JAMA},
  year={2001},
  volume={286 8},
  pages={
          954-9
        }
}

• D. Mukherjee, S. Nissen, E. Topol
• Published 2001
• Medicine
• JAMA

Atherosclerosis is a process with inflammatory features and selective cyclooxygenase 2 (COX-2) inhibitors may potentially have antiatherogenic effects by virtue of inhibiting inflammation. However, by decreasing vasodilatory and antiaggregatory prostacyclin production, COX-2 antagonists may lead to increased prothrombotic activity. To define the cardiovascular effects of COX-2 inhibitors when used for arthritis and musculoskeletal pain in patients without coronary artery disease, we performed a… Expand

View on PubMed

uvm.edu

Save to Library

Create Alert

Cite

Launch Research Feed